Critical Review: Envoy Medical (COCH) vs. Its Competitors

Envoy Medical (NASDAQ:COCH) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its peers? We will compare Envoy Medical to similar businesses based on the strength of its profitability, analyst recommendations, institutional ownership, earnings, dividends, valuation and risk.

Valuation & Earnings

This table compares Envoy Medical and its peers revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Envoy Medical	$240,000.00	-$23.76 million	-1.55
Envoy Medical Competitors	$1.88 billion	$136.81 million	10.34

Envoy Medical’s peers have higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Envoy Medical and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-9,026.41%	-5,250.23%	-110.01%
Envoy Medical Competitors	-304.51%	-178.77%	-22.17%

Institutional & Insider Ownership

8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 7.2% of Envoy Medical shares are held by insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Volatility & Risk

Envoy Medical has a beta of 2.03, indicating that its share price is 103% more volatile than the S&P 500. Comparatively, Envoy Medical’s peers have a beta of 2.57, indicating that their average share price is 157% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and target prices for Envoy Medical and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	1	1	2	0	2.25
Envoy Medical Competitors	4279	10550	18327	829	2.46

Envoy Medical currently has a consensus price target of $21.67, indicating a potential upside of 203.03%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.20%. Given Envoy Medical’s higher probable upside, equities analysts plainly believe Envoy Medical is more favorable than its peers.

Summary

Envoy Medical peers beat Envoy Medical on 11 of the 12 factors compared.

Envoy Medical Company Profile

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.